Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) is a manufacturer, designer and marketer of products & systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The company has been operating in the healthcare industry since the 60s. The healthcare business has been a separate entity since 2001 when the company split from its appliances business.
SomnoMed Limited (ASX:SOM) today reported it achieved 30% revenue growth in its 2018 financial year.
Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO), is down by 0.5% at lunch.
The Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) share price has fallen by 1.39% after reporting its profit result for the full year to 31 March 2018.
Futures contracts for the S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO) index are pointing to a negative open on Monday morning with oil prices, Fortescue Metals Group Limited (ASX:FMG) and Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) in the news.
Shares of the leading Australian biotechnology company ResMed Inc. (CHESS) (ASX:RMD) bounced 8% on Tuesday following a bumper quarterly report.